Syschem India Ltd
Fundamental Score
Syschem India Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of SYSCHEM across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Robust Profit Growth (396.88%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (118.01%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (33.94% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (16.40% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (17.64% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (64.56x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (56.71%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
11 factors identified
Below-Average Return on Equity (0.62%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (1.47%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (1.98%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Premium Valuation Risk (P/E: 52.46x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Negative Free Cash Flow (₹-78.30 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 0.18%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Syschem India Ltd
About SYSCHEM
Business Overview
Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.
Company Details
Key Leadership
Latest News
SYSCHEM Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Syschem India Ltd (SYSCHEM)?
As of 02 Feb 2026, 10:19 am IST, Syschem India Ltd (SYSCHEM) is currently trading at ₹49.57. The stock has a market capitalization of ₹237.63 (Cr).
Is SYSCHEM share price Overvalued or Undervalued?
SYSCHEM is currently trading at a P/E ratio of 52.46x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Syschem India Ltd share price?
Key factors influencing SYSCHEM's price include its quarterly earnings growth (Sales Growth: 118.01%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Syschem India Ltd a good stock for long-term investment?
Syschem India Ltd shows a 5-year Profit Growth of 17.64% and an ROE of 0.62%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does Syschem India Ltd compare with its industry peers?
Syschem India Ltd competes with major peers in the Pharmaceuticals. Investors should compare SYSCHEM's P/E of 52.46x and ROE of 0.62% against the industry averages to determine its competitive standing.
What is the P/E ratio of SYSCHEM and what does it mean?
SYSCHEM has a P/E ratio of 52.46x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹52 for every ₹1 of annual earnings.
How is SYSCHEM performing according to Bull Run's analysis?
SYSCHEM has a Bull Run fundamental score of 58.4/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does SYSCHEM belong to?
SYSCHEM operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Syschem India Ltd.
What is Return on Equity (ROE) and why is it important for SYSCHEM?
SYSCHEM has an ROE of 0.62%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Syschem India Ltd generates profits from shareholders' equity.
How is SYSCHEM's debt-to-equity ratio and what does it indicate?
SYSCHEM has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is SYSCHEM's dividend yield and is it a good dividend stock?
SYSCHEM offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has SYSCHEM grown over the past 5 years?
SYSCHEM has achieved 5-year growth rates of: Sales Growth 33.94%, Profit Growth 17.64%, and EPS Growth 16.40%.
What is the promoter holding in SYSCHEM and why does it matter?
Promoters hold 56.71% of SYSCHEM shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is SYSCHEM's market capitalization category?
SYSCHEM has a market capitalization of ₹238 crores, placing it in the Small-cap category.
How volatile is SYSCHEM stock?
SYSCHEM has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for SYSCHEM?
SYSCHEM has a 52-week high of ₹N/A and low of ₹N/A.
What is SYSCHEM's operating profit margin trend?
SYSCHEM has a 5-year average Operating Profit Margin (OPM) of 1.98%, indicating the company's operational efficiency.
How is SYSCHEM's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 118.01% and YoY Profit Growth of 396.88%.
What is the institutional holding pattern in SYSCHEM?
SYSCHEM has FII holding of 0.00% and DII holding of 0.18%. Significant institutional holding often suggests professional confidence in the stock.